Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Get Rating) has been given a consensus rating of “Hold” by the nine ratings firms that are covering the firm, reports Marketbeat.com. One equity research analyst has rated the stock with a sell recommendation, four
Stay in School With a Home in a One-Room Schoolhouse, Starting at $169,900
One-room schoolhouses are no longer the educational norm that they were for some American children in the 19th century, but they can still be found scattered across the landscape of New York. Those converted into dwellings can often offer petite